Trial Profile
T Cell and Interferon Expression in Tonsils After Sublingual Immunotherapy and/or Nasal Live Attenuated Influenza Vaccine
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary) ; Influenza virus vaccine live (Primary)
- Indications Allergic asthma; Grass pollen hypersensitivity; Influenza virus infections
- Focus Pharmacodynamics
- Acronyms Tons2
- 12 Dec 2013 New source identified and integrated (European Clinical Trials Database record: EudraCT2013-000492-32)
- 01 Oct 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 21 Aug 2013 New trial record